UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019206
Receipt number R000022204
Scientific Title Exploratory study of intraperitoneal paclitaxel combined with mFOLFOX6 for gastric cancer patients with peritoneal metastasis and inadequate oral intake
Date of disclosure of the study information 2016/01/01
Last modified on 2019/04/05 09:39:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Exploratory study of intraperitoneal paclitaxel combined with mFOLFOX6 for gastric cancer patients with peritoneal metastasis and inadequate oral intake

Acronym

Phase I/II study of FOLFOX+IP PTX

Scientific Title

Exploratory study of intraperitoneal paclitaxel combined with mFOLFOX6 for gastric cancer patients with peritoneal metastasis and inadequate oral intake

Scientific Title:Acronym

Phase I/II study of FOLFOX+IP PTX

Region

Japan


Condition

Condition

gastric cancer with peritoneal metastasis

Classification by specialty

Gastroenterology Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety of intraperitoneal paclitaxel combined with mFOLFOX6 in gastric cancer patients with peritoneal metastasis and inadequate oral intake

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase I,II


Assessment

Primary outcomes

1-year overall survival

Key secondary outcomes

progression-free survival
time to treatment failure
response rate
negative conversion rate on peritoneal cytology
safety


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

mFOLFOX6 on days 1 and 15
intraperitoneal paclitaxel on days 1, 8 and 15 in 28days

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1) histologically or cytologically proven gastric adenocarcinoma
2) peritoneal metastasis confirmed by diagnostic imaging, staging laparoscopy or laparotomy
3) difficult to be treated with oral anticancer agents due to inadequate oral intake
4) no previous chemotherapy or previous chemotherapy less than one month without disease progression or severe adverse events
5) adequate organ functions(according to the laboratory data which was taken within 14 days before registration)
neutrophil count > 1,500/mm3
hemoglobin > 8.0 g/dl
platelet count > 100,000/mm3
serum transaminases < 100/UI
total serum bilirubin < 2.0mg/dl
creatinine clearance > 50mL/min
6) Eastern Cooperative Oncology Group performance status 0-2
7) HER2 negative or unknown
8) an expected survival period of more than 3 months.
9) age between 20 and 80 years
10) written informed consent

Key exclusion criteria

1) metastasis to distant organ sites other than the peritoneum, ovary or abdominal lymph nodes
2) other active concomitant malignancies
3) massive ascites which requires frequent drainage for palliation
other severe medical conditions
4) contraindication for fluorouracil, levofolinate, oxaliplatin or paclitaxel
5) past or current severe heart disease
6) severe complications such as interstitial pneumonitis, pulmonary fibrosis, uncontrollable diabetes mellitus, renal failure or liver cirrhosis
7) pregnant or nursing women
8) judged to be unfit to participate in this study by investigators

Target sample size

34


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hironori Ishigami

Organization

The University of Tokyo

Division name

Department of chemotherapy

Zip code


Address

7-3-1, Hongo, Bunkyo-ku, Tokyo

TEL

03-3815-5411

Email

ishigami-tky@umin.net


Public contact

Name of contact person

1st name
Middle name
Last name Hironori Ishigami

Organization

The University of Tokyo

Division name

Department of chemotherapy

Zip code


Address

7-3-1, Hongo, Bunkyo-ku, Tokyo

TEL

03-3815-5411

Homepage URL


Email

ishigami-tky@umin.net


Sponsor or person

Institute

The University of Tokyo

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 09 Month 16 Day

Date of IRB

2015 Year 09 Month 17 Day

Anticipated trial start date

2016 Year 01 Month 01 Day

Last follow-up date

2018 Year 12 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 10 Month 02 Day

Last modified on

2019 Year 04 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022204


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name